Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

NCT01979900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10000

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Vaccae
DRUG: placebo

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]